Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation (PadGau)
Epidemiological Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation
Sponsor: CENTOGENE GmbH Rostock
This observational or N/A phase trial investigates Idiopathic Parkinson Disease and Parkinson Disease and is currently completed. CENTOGENE GmbH Rostock leads this study, which shows 13 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — May 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed
-
Apr 2019 — May 2020 [monthly]
Completed
-
Sep 2018 — Apr 2019 [monthly]
Completed
Status: Terminated → Completed
-
Aug 2018 — Sep 2018 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Completed → Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CENTOGENE GmbH Rostock
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Neustadt an der Saale, Germany , Bangkok, Thailand , Dresden, Germany , Giessen, Germany , Greifswald, Germany , Hamburg, Germany , Hanover, Germany , Krefeld, Germany , Leun, Germany , Rostock, Germany and 4 more locations